Drug · DIN 02533286
PREHEVBRIO
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 6, 2022.
- Drug Identification Number (DIN)
- 02533286
- Company (DIN owner)
- Vbi Vaccines Inc.Ottawa, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Hepatitis b, purified antigen J07BC01
- Class
- Human
- Record last updated
- May 13, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) | 10 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 6, 2022: NOC 29632New Drug Submission (NDS)